CompletedNot Applicable

Cognitive Behavioral Therapy and Chronic Pain Self-Management Within the Context of Opioid Reduction: The EMPOWER Study

United States1,462 participantsStarted 2018-07-24

Plain-language summary

The proposed study will fill several critical gaps in evidence that are preventing patients and physicians from making informed decisions about their pain care. This project will provide patients taking opioids and physicians with the specific evidence they need to choose the most effective route to pain control, reduced pain interference, opioid reduction, and improved role function, thereby improving patient care. The aims of this study are to (1) reduce or contain prescription opioid use while maintaining pain control and (2) compare the effectiveness of the Chronic Pain Self-Management Program (CPSMP), Cognitive Behavioral Therapy for chronic pain (pain-CBT), and no behavioral treatment within the context of patient-centered collaborative opioid tapering (Taper Only). The acronym EMPOWER stands for Effective Management of Pain and Opioid-Free Ways to Enhance Relief.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Chronic non-cancer pain (≥ 6 months in duration) * Currently receiving prescription opioids (≥ 10 MEDD) for ≥ 3 months Exclusion Criteria: * Unable to provide informed consent * Unable to participate in group treatments in a meaningful way (e.g., evident cognitive impairment or lack of English fluency) * Moderate to severe opioid use disorder

What they're measuring

Opioid Tapering Success

Timeframe: Baseline and 12 months

Trial details

NCT IDNCT03445988

SponsorStanford University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-06

Results submitted2025-01-30

View on ClinicalTrials.gov More Chronic Pain trials